Analysis
Life sciences and health care M&A update: Q4 2023
Continued demand and focus in life sciences on speed to market, sustainable strategies, safer installations, and competition for qualified labor are driving alternative approaches to project delivery and design.
Life sciences and health care trends
- Health care services
With patients resuming more normal patterns of care following the pandemic, hospitals are witnessing positive margin stabilization.1 - Health care technology
Despite a decrease in EBITDA performance, sentiment surrounding health care technology has resulted in rising enterprise values through Q4 2023.2 - Life sciences and pharma services
Continued demand and focus in Life Sciences on speed to market, sustainable strategies, safer installations, and competition for qualified labor are driving alternative approaches to project delivery and design.3 - Medical devices and supplies
Overall trends in the medical device sector point toward optimism, propelled by a continued rise in digital therapeutics and at-home diagnostics, growing use of biometric devices, and increased speed to market.4 - Payors and payor services
Payors and Payor services faced challenges in 2023, including ongoing Medicaid redeterminations and increased Medicare usage, but stability is anticipated in 2024.5
This newsletter is a periodic compilation of certain capital markets information.
References
1. DPR Construction. Healthcare Market Trends Q4 2023
2. Aprio Insights. 6 Healthcare Insights from Q4 2023 and What They Mean for You
3. PwC, Health services: Pharmaceutical and life sciences: US Deals 2024 outlook
4. AlphaSense, Top Medical Device Trends & Outlook for 2024
5. Healthedge, Navigating the Payer-Provider Landscape: Wins, Losses, and Future Trends
Previous editions
- Life Sciences & Health Care M&A quarterly update: Q3 2023
- Life Sciences & Health Care M&A quarterly update: Q2 2023
- Life Sciences & Health Care M&A quarterly update: Q1 2023
- Life Sciences & Health Care M&A quarterly update: Q3 2022
- Life sciences and health care M&A update: Q2 2022
- Life sciences and health care M&A update: Q1 2022
- Life sciences and health care M&A update: Q4 2021
- Life sciences and health care M&A update: Q2 2021
- Life sciences and health care M&A update: Q1 2021
- Life sciences & health care M&A update: Q4 2020
- Life sciences & health care M&A update: Q2 2020
- Life sciences & health care M&A update: Q1 2020
- Life sciences & health care M&A update: Q4 2019
- Life sciences & health care M&A update: Q2 2019
- Life sciences & health care M&A update: Q1 2019
- Life sciences & health care M&A update: Q4 2018
- Life sciences & health care M&A update: Q3 2018
- Life sciences & health care M&A update: Q2 2018
- Life sciences & health care M&A update: Q1 2018
- Life sciences & health care M&A update: Q4 2017
- Life sciences & health care M&A update: Q3 2017
- Life sciences & health care M&A update: Q2 2017
- Life sciences & health care M&A update: Q4 2016